个人简介

于凤刚，博士，教授。于中国预防医学科学院传染病预防控制所获博士学位，加拿大多伦多大学博士后。2020年2月入职银丰生物集团，任生科院副院长，同时被聘为济南大学教授。另外还涉及EB病毒感染和鼻咽癌发病机制的研究。 主持课题 1. Prospective isolation of cancer stem cells (CSCs) from nasopharyngeal cancer (NPC) primary tumor biopsies. NMRC central grant/NCIS Pilot grant. S$30,000 (PI). 2. Integrated analysis of somatic mutations and genomic aberrations in nasopharyngeal carcinoma (NPC). Terry Fox Foundation Grant. S$140,000 (Co-Investigator) 3. Genetic Polymorphisms and the Risk of Cisplatin-induced Ototoxicity in Asian Children. National University Hospital, University Children's Medical Institute (UCMI) grant. S$25,000. (Collaborator). 4. Intracellular redox milieu as a potential therapeutic target in NPC Cancer Stem Cells. National University Cancer Institute (NCIS) Centre Grant-Pilot Grant.S$30,000 (Co-Investigator) 5. Establishment of primary human nasal epithelial stem/progenitor cells in an air-liquid interface culture model and identification of their roles in infectious and allergic disease of the upper airway. A*STAR - SIgN 10-028. S$363,000(Co-Investigator) 6. TLR-3 ligand as an immune adjuvant in cetuximab based therapy in Head and Neck Cancer. NMRC/RIG grant. S$200,000. (Co-PI) 7. CD21-Mediated Entry and Stable Infection by Epstein - Barr virus in NPC and normal nasopharyngeal epithelial cells. NCIS- YONG SIEW YOON RESEARCH GRANT. S$200,000. (Co-PI) 8. Gene and MiRNA expression analysis of cancer-associated fibroblasts in nasopharyngeal carcinoma. NUHS Clinician Research Grant FY2013. $90,000. (Co-Investigator) 9. Nasal Pharyngeal Cancer: Team approach to cure. S$969,000 (Collaborator) 10. Ex vivo culture and molecular characterization of circulating NPC tumor cells potentially for individualized drug testing. NCIS Centre Grant FY2013-2016, Seed Funding Program. S$100,000 (PI). 11. The development of an orthotopic model of metastatic nasopharyngeal carcinoma using patient circulating tumor cells: implications for novel therapeutics. S$100,000. NUHS BENCH-TO-BEDSIDE (B2B) 2016. Lead PI 获奖 Winner of 2014 Yamagiwa-Yoshida Memorial International Cancer Study Fellowship/Union for International Cancer Control (UICC)